Partial Spin-Off Declared By This Massive Therapeutics Company

Altamira Therapeutics Announces Partial Spin-Off of Bentrio® Business: A Strategic Move Towards the Future.

Altamira Therapeutics, a pioneer in the biopharmaceutical industry, has recently announced a significant shift in its business model. The company is partially spinning off its Bentrio® business, a strategic move that aims to focus on Altamira's core RNA delivery technology. This decision has stirred interest in the industry, with many seeing it as a sig…